DAB2IP and prostate cancer: However, the expression level of miR-149 is increased in prostate cancer, which can enhance motility and invasiveness of cancer cells by downregulating DAB2IP and promote activation of NF-κB signaling and expression of proangiogenic factors to enhance tumor progression [26].